Treatment of bacterial diseases of the respiratory organs
The invention relates to inhalable quinolonecarboxylic acid derivative compositions for local control of diseases of the respiratory organs, in particular of lung diseases.
1. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of a ciprofloxacin embonate or enrofloxacin embonate, in a powder form or powder-containing suspension.
2. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of a ciprofloxacin hemiembonate or enrofloxacin hemiembonate, in a powder form or powder-containing suspension.
3. A method of treating a bacterial disease of the lungs in a human or animal comprising the step of locally administering an antibacterially effective amount of:
a mixture of ciprofloxacin embonate and ciprofloxacin hemiembonate, or
a mixture of enrofloxacin embonate and enrofloxacin hemiembonate,
in a powder form or powder-containing suspension.